Extensive evidence indicates that IL-23 is involved in regulating mucosal inflammatory responses in the gut and plays crucial roles in the pathophysiology of several diseases, including inflammatory bowel disease, ulcerative colitis, and Crohn’s disease (11–14). This evidence concerns the gene IL37 and inflammatory bowel disease.